Amgen (AMGN) PT Lowered to $217 at RBC Capital
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $442.36 +4.02%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $217.00 (from $220.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Amgen (AMGN) PT Raised to $362 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
